US LABS

US LABS is a specialized anatomic pathology laboratory focused on providing high-complexity cancer diagnostic testing services. The company serves community-based pathologists, oncologists, and hospitals, offering advanced technologies such as flow cytometry, cytogenetics, and fluorescence in situ hybridization (FISH). US LABS is particularly recognized for its expertise in breast cancer testing, including HER2/neu protein expression and gene amplification analysis. In 2005, the company was acquired by LabCorp, significantly expanding the parent company's oncology testing capabilities and clinical trial support services. Today, its legacy continues as part of LabCorp's integrated oncology platform, providing critical diagnostic data for personalized medicine.